Financial Express (Holdings) Limited (“we”, “our”, “us” and derivatives) are committed to protecting and respecting your privacy. This Privacy Policy, together with our Terms of Use, sets out the basis on which any personal data that we collect from you, or that you provide to us, will be processed by us relating to your use of any of the below websites (“sites”).


For the purposes of the Data Protection Act 1998, the data controller is Trustnet Limited of 2nd Floor, Golden House, 30 Great Pulteney Street, London, W1F 9NN. Our nominated representative for the purpose of this Act is Kirsty Witter.


We collect information about you when you register with us or use any of our websites / services. Part of the registration process may include entering personal details & details of your investments.

We may collect information about your computer, including where available your operating system, browser version, domain name and IP address and details of the website that you came from, in order to improve this site.

You confirm that all information you supply is accurate.


In order to provide personalised services to and analyse site traffic, we may use a cookie file which is stored on your browser or the hard drive of your computer. Some of the cookies we use are essential for the sites to operate and may be used to deliver you different content, depending on the type of investor you are.

You can block cookies by activating the setting on your browser which allows you to refuse the setting of all or some cookies. However, if you use your browser settings to block all cookies (including essential cookies) you may not be able to access all or part of our sites. Unless you have adjusted your browser setting so that it will refuse cookies, our system will issue cookies as soon as you visit our sites.


We store and use information you provide as follows:

  • to present content effectively;
  • to provide you with information, products or services that you request from us or which may interest you, tailored to your specific interests, where you have consented to be contacted for such purposes;
  • to carry out our obligations arising from any contracts between you and us;
  • to enable you to participate in interactive features of our service, when you choose to do so;
  • to notify you about changes to our service;
  • to improve our content by tracking group information that describes the habits, usage, patterns and demographics of our customers.

We may also send you emails to provide information and keep you up to date with developments on our sites. It is our policy to have instructions on how to unsubscribe so that you will not receive any future e-mails. You can change your e-mail address at any time.

In order to provide support on the usage of our tools, our support team need access to all information provided in relation to the tool.

We will not disclose your name, email address or postal address or any data that could identify you to any third party without first receiving your permission.

However, you agree that we may disclose to any regulatory authority to which we are subject and to any investment exchange on which we may deal or to its related clearing house (or to investigators, inspectors or agents appointed by them), or to any person empowered to require such information by or under any legal enactment, any information they may request or require relating to you, or if relevant, any of your clients.

You agree that we may pass on information obtained under Money Laundering legislation as we consider necessary to comply with reporting requirements under such legislation.


We want to ensure that the personal information we hold about you is accurate and up to date. You may ask us to correct or remove information that is inaccurate.

You have the right under data protection legislation to access information held about you. If you wish to receive a copy of any personal information we hold, please write to us at 3rd Floor, Hollywood House, Church Street East, Woking, GU21 6HJ. Any access request may be subject to a fee of £10 to meet our costs in providing you with details of the information we hold about you.


The data that we collect from you may be transferred to, and stored at, a destination outside the European Economic Area (“EEA”). It may be processed by staff operating outside the EEA who work for us or for one of our suppliers. Such staff may be engaged in, amongst other things, the provision of support services. By submitting your personal data, you agree to this transfer, storing and processing. We will take all steps reasonably necessary, including the use of encryption, to ensure that your data is treated securely and in accordance with this privacy policy.

Unfortunately, the transmission of information via the internet is not completely secure. Although we will do our best to protect your personal data, we cannot guarantee the security of your data transmitted to our sites; any transmission is at your own risk. You will not hold us responsible for any breach of security unless we have been negligent or in wilful default.


Any changes we make to our privacy policy in the future will be posted on this page and, where appropriate, notified to you by e-mail.


Our sites contain links to other websites. If you follow a link to any of these websites, please note that these websites have their own privacy policies and that we do not accept any responsibility or liability for these policies. Please check these policies before you submit any personal data to these websites.


If you want more information or have any questions or comments relating to our privacy policy please email [email protected] in the first instance.

 Information  X 
Enter a valid email address

Plant Impact PLC (PIM)

  Print      Mail a friend       Annual reports

Monday 17 July, 2017

Plant Impact PLC

Full Year Trading Update & Potential Capital Raise

RNS Number : 2134L
Plant Impact PLC
17 July 2017

The Company considers that this announcement contains inside information for the purposes of the Market Abuse Regulation


For immediate release                                                                                                                                17 July 2017

Plant Impact plc

("Plant Impact", the "Company" or together with its subsidiaries, the "Group")

Full Year Trading Update and Potential Capital Raise

Plant Impact plc (AIM: PIM) leads research and development in crop enhancement technology to create products that growers can rely on to increase the yield and quality of their crops.  Today the Group announces a pre-close trading update for the year ending 31 July 2017 ("FY17").

On 19 June 2017, the Company announced that it was in contract discussions with Bayer CropScience Brazil ("Bayer"), the Company's partner in Brazil and the exclusive marketer of the Company's flagship soybean product, Veritas®.  These discussions aim to revise the structure of the Company's contract with Bayer to provide greater inventory purchase flexibility for Bayer and more predictable income and earnings visibility for the Company.  The contract discussions continue to progress positively but are expected to take some time to conclude.  Bayer remains fully committed to the commercial development of Veritas®, which during its first four years of sales has grown to be the leading biostimulant in the Brazilian soybean market.  

Bayer has set end-user sales targets for the 2017/18 growing season, which anticipate strong growth in grower usage of Veritas® building on Bayer's achievements of the past two growing seasons. This has driven an agreed plan for new purchases of Veritas® commencing in the first half of the Company's financial year ending 31 July 2018 ("FY18"). However, to reduce current stock levels in the market, the Company has agreed to cancel early season shipments previously anticipated for July 2017. 

Consequently, the Company now expects revenue for FY17 of between £8.5m and £9.0m, compared with £7.2m in the previous year. Further to this, revenues for FY18 are expected, at this early stage, to be around £13m, based on the new purchasing plan agreed with Bayer and also the Group's growth expectations in other markets such as the United States and West Africa.

The Group's cash balance at 31 July 2017 is expected to be around £3.2m. The Company's commercial business plan for next year anticipates good cash flow generation before investments in research and development. The Company now has a significant number of product development projects in the final stages of pre-commercial testing, and the Board has determined that it is in the best interest of shareholders to sustain the momentum of the R&D supporting these projects.  With this in mind, the Board is considering an equity fund-raise of a minimum of £2.0m, for which it has received an indicative commitment for the full amount from an existing institutional investor at a price of 31.0 pence per share. In addition to this commitment, the Board would consider placing an additional £2.0m of new funds at this price and as such the Company will be meeting with existing and prospective shareholders shortly to identify any additional interest.

For further information please contact: 

Plant Impact plc

John Brubaker, Chief Executive Officer

Richard Amos, Chief Financial Officer

Ailish Tracy, Global Communications Manager


Tel: +44 (0) 1582 465 540


Peel Hunt - Nominated Advisor and Broker

Adrian Trimmings

George Sellar


Buchanan - Financial PR

Mark Court

Sophie Cowles

Jamie Hooper

Tel: +44 (0) 207 418 8900



Tel: +44 (0) 207 466 5000




This information is provided by RNS
The company news service from the London Stock Exchange

a d v e r t i s e m e n t